{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:50:18Z","timestamp":1770958218239,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"InCarda Therapeutics, Inc."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijcard.2018.09.029","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T16:02:23Z","timestamp":1536422543000},"page":"170-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration"],"prefix":"10.1016","volume":"274","author":[{"given":"Alexandre A.","family":"Marum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre L.","family":"Bortolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson C.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Z.","family":"de Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Belardinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard L.","family":"Verrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.09.029_bb0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0010","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent onset atrial fibrillation with the \u201cpill-in-the-pocket\u201d approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/hrt.2009.187963","article-title":"Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during \u201cpill-in-the-pocket\u201d treatment","volume":"96","author":"Alboni","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hrthm.2017.10.002","article-title":"Clinical effectiveness of a systematic \"pill-in-the-pocket\" approach for the management of paroxysmal atrial fibrillation","volume":"15","author":"Andrade","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0025","first-page":"705","article-title":"The conversion of paroxysmal or initial onset atrial fibrillation with oral ranolazine: implications for a new \u201cpill-in-pocket\u201d approach in structural heart disease","volume":"2","author":"Murdock","year":"2010","journal-title":"J. Atr. Fibrillation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0035","article-title":"PK and QRS interval prolongation of inhaled flecainide [abstract]","volume":"136","author":"Belardinelli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0040","article-title":"Cardiovascular effects of inhaled vs intravenous flecainide [abstract]","volume":"136","author":"Belardinelli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0045","first-page":"S240","article-title":"Rapid cardioversion of acute-onset atrial fibrillation with pulmonary delivery of flecainide in anesthetized dogs [abstract]","volume":"14","author":"Belardinelli","year":"2017","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2018.06.036","article-title":"Accelerated conversion of atrial fibrillation in normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model","author":"Verrier","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/jce.13708","article-title":"Pulmonary delivery of flecainide causes a rate-dependent predominant effect on atrial compared to ventricular depolarization duration revealed by intracardiac recordings in an intact pig model","author":"De Antonio","year":"2018","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.87.2.562","article-title":"Flecainide-induced arrhythmia in canine ventricular epicardium: phase 2 reentry?","volume":"87","author":"Krishnan","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1152\/physrev.1989.69.4.1049","article-title":"Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction","volume":"69","author":"Janse","year":"1989","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1540-8167.2009.01437.x","article-title":"Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart","volume":"20","author":"Kumar","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0075","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1023\/A:1021176123007","article-title":"Bi-atrial mapping of atrial arrhythmias","volume":"6","author":"Lemery","year":"2002","journal-title":"Card. Electrophysiol. Rev."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0008-6363(03)00543-1","article-title":"Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs","volume":"60","author":"Wirth","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2018.09.029_bb0085","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/CIRCULATIONAHA.106.677369","article-title":"View-synchronized robotic image-guided therapy for atrial fibrillation ablation: experimental validation and clinical feasibility","volume":"115","author":"Reddy","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.09.029_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000000605","article-title":"Comparative pharmacokinetic and electrocardiographic effects of intratracheal and intravenous administration of flecainide in anesthetized pigs","volume":"72","author":"Stocco","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318345613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T02:15:06Z","timestamp":1546654506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318345613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":18,"alternative-id":["S0167527318345613"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.029","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}